Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Journal of Molecular Neuroscience : MN
|
June 13, 2002
A phase I study of AIT-082 in healthy elderly volunteers
Michael Grundman, Martin Farlow, Guerry Peavy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Clinical and molecular characterization of patients with cancer of unknown primary in the modern era
A M Varghese, A Arora, M Capanu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J Mateo, D Chakravarty, R Dienstmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Oncologist use and perception of large panel next-generation tumor sequencing
A M Schram, D Reales, J Galle, et al.
Archives of Neurology
|
January 21, 2004
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials
Michael Grundman, Ronald C Petersen, Steven H Ferris, et al.
Head & Neck
|
August 3, 2004
Parathyroid carcinoma: a 22-year experience
Naifa L Busaidy, Camilo Jimenez, Mouhammed Amir Habra, et al.
Mutation Research
|
June 12, 1996
The detection and evaluation of aneugenic chemicals
J M Parry, E M Parry, R Bourner, et al.
High Altitude Medicine & Biology
|
March 21, 2006
Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial
Buddha Basnyat, Jeffrey H Gertsch, Peter S Holck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Journal of Molecular Neuroscience : MN
|
June 13, 2002
A phase I study of AIT-082 in healthy elderly volunteers
Michael Grundman, Martin Farlow, Guerry Peavy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Clinical and molecular characterization of patients with cancer of unknown primary in the modern era
A M Varghese, A Arora, M Capanu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J Mateo, D Chakravarty, R Dienstmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Oncologist use and perception of large panel next-generation tumor sequencing
A M Schram, D Reales, J Galle, et al.
Archives of Neurology
|
January 21, 2004
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials
Michael Grundman, Ronald C Petersen, Steven H Ferris, et al.
Head & Neck
|
August 3, 2004
Parathyroid carcinoma: a 22-year experience
Naifa L Busaidy, Camilo Jimenez, Mouhammed Amir Habra, et al.
Mutation Research
|
June 12, 1996
The detection and evaluation of aneugenic chemicals
J M Parry, E M Parry, R Bourner, et al.
High Altitude Medicine & Biology
|
March 21, 2006
Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial
Buddha Basnyat, Jeffrey H Gertsch, Peter S Holck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Page
of 10